• 7455 Citations
  • 36 h-Index
1987 …2024
If you made any changes in Pure these will be visible here soon.

Research Outputs 1987 2019

Filter
Meeting abstract
2016

Case series: silent malignant spinal cord compression (MSCC) secondary to spinal epidural metastases (SEM) in castrate-resistant prostate cancer (CRPC)

Park, J. J., Sabanathan, D., Lau, A. & Gurney, H., 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, Suppl. S3, p. 38-38 1 p.

Research output: Contribution to journalMeeting abstractResearch

Case series: silent malignant spinal cord compression (MSCC) secondary to spinal epidural metastases (SEM) in castrate-resistant prostate cancer (CRPC)

Park, J., Sabanathan, D., Lau, A. & Gurney, H., 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, Suppl. S4, p. 66-66 1 p.

Research output: Contribution to journalMeeting abstractResearch

Differences in the patterns of anti-pd1 (PD1) toxicity between tumor streams

Sabanathan, D., Kong, B., Byrne, N., Wegener, V., Eslick, G., Nagrial, A., Hui, R., Kefford, R., Gurney, H. & Carlino, M. S., 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, Suppl. S4, p. 68-68 1 p.

Research output: Contribution to journalMeeting abstractResearch

MILGa-01-a first in human study assessing the safety and tolerability of chMIL-38 in prostate cancer

Sabanathan, D., Gurney, H., Gillatt, D., Trifunovic, M., Magnussen, J., Poursoltan, P., Shon, K. H. O., Walsh, B. J., Mazure, H., Velonas, V., Thurecht, K., Quach Truong, Wissmueller, S. & Campbell, D., Aug 2016, In : BJU international. 118, Suppl. 1, p. 14-15 2 p.

Research output: Contribution to journalMeeting abstractResearch

Real-world experience of the feasibility and tolerability of the 2:1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia

Crumbaker, M., Gurney, H., Guminski, A., Wong, S., Sabanathan, D. & Pavlakis, N., Jul 2016, In : Asia-Pacific Journal of Clinical Oncology. 12, S3, p. 47 1 p., abs#209.

Research output: Contribution to journalMeeting abstractResearch

2015

CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

Motzer, R. J., Escudier, B., Mcdermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Xu, L-A., Waxman, I. M., Sharma, P. & 1 others CheckMate 025 Investigators, Dec 2015, In : BJU international. 116, S5, p. 17 1 p.

Research output: Contribution to journalMeeting abstractResearch

CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)

Sharma, P., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Xu, L. A., Waxman, I. M. & Motzer, R. J., Sep 2015, In : European Journal of Cancer. 51, Supplement 3, p. S708 1 p.

Research output: Contribution to journalMeeting abstractResearch

2013

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Yeap, S. H., Ali, S. S., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2013, In : Journal of Clinical Oncology. 31, 15 supplement, p. 1-1 1 p., 543.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation

Fox, P., Gao, B., Balakrishnar, B., Menzies, A. M., Gebski, V., Provan, P., Coulter, S., Liddle, C., Hui, R., Kefford, R., Lynch, J., Wilcken, N., Balleine, R. L. & Gurney, H., 1 Jul 2013, In : Asia-Pacific Journal of Clinical Oncology. 9, Supplement 2, p. 45-45 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

2012

Accelerated BEP for metastatic germ cell tumors: combined analysis of Australian and UK phase I/II trials

Grimison, P. S., Chatfield, M. D., Mazhar, D., Toner, G. C., Chester, J. D., Stockler, M. R., Stark, D. P., Thomson, D. B., Shamash, J., Friedlander, M., White, J., Gebski, V., Wason, J., Boland, A. L., Rimmer, Y. L., McDonald, A., Gurney, H., Rosenthal, M., Singhal, N., Williams, M. V. & 2 othersAustralian New Zealand Urogenital & West Anglia Cancer Research Network, 20 May 2012, In : Journal of Clinical Oncology. 30, 15 supplement, p. 4531-4531 1 p.

Research output: Contribution to journalMeeting abstractResearch

Concomitant CYP2D6 inhibitor use and plasma metabolite levels in breast cancer patients treated with tamoxifen

Fox, P., Balakrishnar, B., Menzies, A., Liddle, C., Coulter, S., Provan, P., Gebski, V., Hui, R., Kefford, R., Wilcken, N., Balleine, R. & Gurney, H., 31 Jul 2012, In : Asia-Pacific Journal of Clinical Oncology. 8, Supplement 2, p. 52-52 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

CYP2D6 genotype and adverse effects as indicators of plasma endoxifen in breast cancer patients taking tamoxifen

Balakrishnar, B., Menzies, A. M., Ali, S. S., Yeap, S. H., Gao, B., Liddle, C., Coulter, S., Provan, P., Gebski, V., Hui, R., Kefford, R., Wilcken, N., Balleine, R. L. & Gurney, H., 20 May 2012, In : Journal of Clinical Oncology. 30, Supplement 15, p. 550-550 1 p.

Research output: Contribution to journalMeeting abstractResearchpeer-review

2011

Accelerated BEP for advanced germ cell tumors: an Australian multicenter phase I/II trial.

Grimison, P. S., Thomson, D. B., Stockler, M. R., Chatfield, M. D., Friedlander, M., Gebski, V., Boland, A. L., Houghton, B. B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A., Toner, G. C. & Australian New Zealand Urogenital, 20 May 2011, In : Journal of Clinical Oncology. 29, 15 supplement, p. 4561-4561 1 p.

Research output: Contribution to journalMeeting abstractResearch

The effect of pulmonary function testing on bleomycin dosing in germ cell tumors

Houghton, B. B., Grimison, P. S., Toner, G. C., Chatfield, M., Thomson, D. B., Friedlander, M., Gebski, V., Rosenthal, M., Gurney, H. & Stockler, M., 1 Mar 2011, In : Journal of Clinical Oncology. 29, 7 supplement, p. 227-227 1 p.

Research output: Contribution to journalMeeting abstractResearch

2009

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumors: updated analysis of a randomized trial with 8 years follow-up

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gurney, H., Lewis, C. R., Gebski, V. J., Boland, A. L., Toner, G. C. & Australia New Zealand Germ Cell, 20 May 2009, In : Journal of Clinical Oncology. 27, 15, p. 5016-5016 2 p.

Research output: Contribution to journalMeeting abstractResearch

1990

A phase-I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving intensive chemotherapy for small-cell lung-cancer

Anderson, H., Gurney, H., Radford, J., Steward, WP., Kamthan, A., Chang, J. & Thatcher, N., Sep 1990, In : British Journal of Cancer. 62, 3, p. 528-528 1 p.

Research output: Contribution to journalMeeting abstractResearch

A phase-II study of ifosfamide and alpha-2 interferon (intron-A) in advanced non-small cell lung-cancer

Lind, MJ., Thatcher, N., Gurney, H. & Kamthan, A., Sep 1990, In : British Journal of Cancer. 62, 3, p. 502-502 1 p.

Research output: Contribution to journalMeeting abstractResearch